LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 128 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $534,546 | -23.0% | 8,921 | +253.0% | 0.00% | -60.0% |
| Q3 2018 | $694,000 | +1726.3% | 2,527 | +1265.9% | 0.01% | – |
| Q2 2018 | $38,000 | -74.5% | 185 | -79.5% | 0.00% | -100.0% |
| Q1 2018 | $149,000 | -22.4% | 904 | -35.5% | 0.00% | 0.0% |
| Q4 2017 | $192,000 | -59.1% | 1,401 | -59.3% | 0.00% | -75.0% |
| Q3 2017 | $469,000 | -88.3% | 3,442 | -90.9% | 0.00% | -91.3% |
| Q1 2017 | $3,993,000 | +62.8% | 37,729 | +56.3% | 0.05% | +91.7% |
| Q4 2016 | $2,452,000 | +3453.6% | 24,136 | +3491.7% | 0.02% | +2300.0% |
| Q3 2016 | $69,000 | -57.9% | 672 | -56.1% | 0.00% | -50.0% |
| Q1 2016 | $164,000 | -54.4% | 1,532 | -53.9% | 0.00% | -50.0% |
| Q4 2015 | $360,000 | +92.5% | 3,320 | +52.3% | 0.00% | +33.3% |
| Q3 2015 | $187,000 | -59.3% | 2,180 | -52.2% | 0.00% | -50.0% |
| Q2 2015 | $460,000 | +79.7% | 4,562 | +37.7% | 0.01% | +50.0% |
| Q1 2015 | $256,000 | +2227.3% | 3,314 | +1280.8% | 0.00% | – |
| Q3 2014 | $11,000 | -90.6% | 240 | -91.2% | 0.00% | -100.0% |
| Q3 2013 | $117,000 | – | 2,714 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |